Last update 08 May 2025

Mecamylamine/Nicotine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
Muscle-type nAChRs x nAChRα1/β1/δ/γ
Action
agonists
Mechanism
AChR agonists(Cholinergic receptors agonists), Muscle-type nAChRs agonists(Muscle-type nicotinic acetylcholine receptor agonists)
Therapeutic Areas
Other Diseases
Active Indication-
Inactive Indication
Tobacco Use Disorder
Originator Organization
Elan Pharma International Ltd.
Active Organization-
Inactive Organization
Elan Corp. PlcElan Corp. Plc
License Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC11H21N
InChIKeyIMYZQPCYWPFTAG-UHFFFAOYSA-N
CAS Registry60-40-2
View All Structures (2)

Related

100 Clinical Results associated with Mecamylamine/Nicotine
Login to view more data
100 Translational Medicine associated with Mecamylamine/Nicotine
Login to view more data
100 Patents (Medical) associated with Mecamylamine/Nicotine
Login to view more data
100 Deals associated with Mecamylamine/Nicotine
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Tobacco Use DisorderPhase 3-
Elan Corp. PlcElan Corp. Plc
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free